Dr. Mundorf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1718 E 4th St
Ste 908
Charlotte, NC 28204Phone+1 704-334-3222Fax+1 704-334-1532
Education & Training
University of Louisville School of MedicineResidency, Ophthalmology, 1986 - 1987
Wake Forest University Baptist Medical CenterResidency, Ophthalmology, 1983 - 1986- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1982 - 1983
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1982
Certifications & Licensure
NC State Medical License 1983 - 2025
SC State Medical License 1997 - 1997
Clinical Trials
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 5 citationsEffects of Netarsudil on the Corneal Endothelium: Three-Month Findings from a Phase 3 Trial.Thomas Mundorf, Francis S. Mah, Huan Sheng, Theresa Heah
Ophthalmology. Glaucoma. 2020-04-29 - 33 citationsBimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomis...Douglas G. Day, Thomas R Walters, Gail F. Schwartz, Thomas K Mundorf, Charlie Liu
The British Journal of Ophthalmology. 2013-08-01 - 77 citationsA phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.Charles P. Semba, Gail Torkildsen, John Lonsdale, Eugene B McLaurin, Joel A. Geffin
American Journal of Ophthalmology. 2012-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
